F 0726
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure that nurses and nurse aides have the appropriate competencies to care for every resident in a way
that maximizes each resident's well being.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure a routine medication was available for one of three
sampled residents (Resident 1).
This failure resulted in Resident 1 not receiving scheduled medication and caused the resident distress.
Findings:
During an interview on 3/7/25 at 3:40 p.m. with the director of nursing (DON), the DON stated Resident 1
was admitted on [DATE] at 5:30 p.m. The list of medications was sent electronically to the pharmacy and
the facility eventually received delivery of the medications from the pharmacy. Missing from the medications
was Alprazolam (medication for anxiety) 2 mg (milligrams). Resident 1 takes Alprazolam 2 mg. at bedtime
routinely.
During a telephone interview on 3/7/25 at 4:20 p.m. with the pharmacist, the pharmacist stated all
controlled medications need to be faxed to the pharmacy. The facility can send medication requests, even
controlled medications electronically but a fax still needs to be sent for any controlled medication. The only
exception for not sending a fax for a controlled medication is when the doctor/prescriber sends the order
electronically directly to the pharmacy.
During an interview on 3/7/25 at 4:50 p.m. with admitting nurse (LN 1), LN 1 stated admitted Resident 1 on
3/4/25 at 5:30 p.m., reconciled the medications, sent the medication list electronically to the pharmacy and
called the pharmacy to confirm they received the requested medication list sent. LN 1 admitted was not
aware a fax had to be sent for the controlled medication, Alprazolam 2 mg.
During a review of Resident 1's Nursing Progress Notes (Notes), dated 3/4/25 at 10:42 p.m., the Notes
indicated, LN 2 documented, Medication did not arrive with pharmacist sender. Will call and get information
on it . There were no further updates/documentation regarding the missing Alprazolam or attempt to call the
physician to request an alternative medication.
During a review of Resident 1's Notes, dated 3/5/25 at 10:56 p.m., LN 4 documented, Patient was upset
Alprazolam wasn't here. This writer explained to pt (patient) that I will call pharmacy for ETA (Estimated
Time of Arrival) of med.(medication) MD notified requesting alternative med d/t (due/to) Alprazolam not
available. Resident 1's Representative was very upset and signed Resident 1 out of the facility AMA
(Against Medical Advise) on 3/5/25 at 10 p.m.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
055563
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055563
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/11/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Santa Maria Post Acute
820 West Cook Street
Santa Maria, CA 93458
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0726
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During an interview on 3/7/25 at 4:55 p.m with the DON, the DON stated LN 2 called the pharmacy to
follow up on the medications. Pharmacy did not respond since it was close to midnight. LN 2 gave report to
oncoming nurse, LN 3 (day shift [7A - 7P]) to follow up with the pharmacy. LN 3 did not document any follow
up with pharmacy. LN 4 documented on 3/5/25 at 10:56 p.m., that Resident 1's Alprazolam 2 mg has still
not been delivered by pharmacy. When DON was asked why LN 1 was unaware of faxing an order for
controlled medication(s), why LN 2 & 3 did not call the doctor to request an alternate medication (Ativan)
which was available in the e-kit, the DON did not have an answer.
During a review of the facility's policy and procedure (P&P) titled, Ordering and Receiving Controlled
Medications, dated 2023, the P&P indicated in part, Medications included in the Drug Enforcement
Administration (DEA) classification as controlled substances, and medications classified as controlled
substances by state law, are subject to special ordering, receipt, and record keeping requirements in the
facility, in accordance with federal and state laws and regulations. And C. New and refill orders for controlled
medications are ordered as detailed in the procedure for Ordering and Receiving Medications from
Dispensing Pharmacy. When a physician's signature is needed to validate a controlled drug refill, a facility
specific Control Drug Order form can be completed by the physician or physician's agent, signed by the
physician and faxed to the pharmacy.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055563
If continuation sheet
Page 2 of 2